BUY UTI Asset Management Company Limited — ICICI Securities
byICICI SecuritiesHorizon: NA (inferred 1 year)3 Nov 2026via Institutional / Brokerage Research
Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.
AI Assessment
Automated market context for this BUY call — facts from public sources, machine-classified. Not investment advice.
3 other SEBI-registered advisors have active long-term BUY calls on this stock, with 2 issued in the last 14 days
Advisor consensus · same horizon·28 Oct · 1w ago
UTI Asset Management Company reported its financial results for the quarter and half-year ended September 30, 2026, showing a consolidated core profit after tax of ₹263 crore for H1 FY27, a 15% increa
BSE · Company Update·23 Oct · 2w ago
UTI Asset Management Company Limited reported its financial results for the quarter and half-year ended September 30, 2026, showing a 15% YoY increase in Core PAT to ₹263 crore for H1 FY27.
NSE · Press Release·23 Oct · 2w ago
Nothing found in this tip’s window yet.
Long-term trend bearish — 200-day average falling over the past quarter
Technicals · trend·6 Nov · yesterday
Factor classifications are AI-generated from exchange filings, verified news feeds and market data — they can be wrong or incomplete, and are not attributed to the issuing analyst. Verify every factor via its linked original before acting. This is not investment advice.
Other calls on UTI Asset Management Company
- BUY — Elara Capital28 Oct 2026 · ~1 year · target ₹960 · Active
- BUY — Motilal Oswal28 Oct 2026 · ~1 year · target ₹1,040 · Active
- BUY — ICICI Securities27 Jul 2026 · ~1 year · target ₹1,040 · Active
- BUY — Motilal Oswal23 Jul 2026 · ~1 year · target ₹1,080 · Active
- BUY — Elara Capital23 Jul 2026 · ~1 year · target ₹1,060 · Active
More from ICICI Securities
- BUY ICICI Bank5 Nov 2026 · ~1 year · target ₹1,800 · Active
- BUY Stylam Industries5 Nov 2026 · ~1 year · target ₹3,750 · Active
- BUY Emcure Pharmaceuticals5 Nov 2026 · ~1 year · target ₹2,560 · Active
- BUY Saregama India5 Nov 2026 · ~1 year · target ₹740 · Active
- BUY Procter & Gamble Health4 Nov 2026 · ~1 year · target ₹6,680 · Active

